Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations
2004 ◽
Vol 50
(4)
◽
pp. 1286-1295
◽
Dirk Foell
◽
Helmut Wittkowski
◽
Inga Hammerschmidt
◽
Nico Wulffraat
◽
Heinrike Schmeling
◽
...
1974 ◽
Vol 3
(2)
◽
pp. 103-108
◽
Anna-Liisa Laaksonen
◽
Veli Koskiahde
◽
Kale Juva
1991 ◽
Vol 11
(6)
◽
pp. 597-605
Sachiko Sugawara
◽
Shoichiro Irimajiri
◽
Torakichi Aoki
◽
Shuichi Yokoyama
◽
Sanae Ida
◽
...
1959 ◽
Vol 5
(1)
◽
pp. 263-274
1964 ◽
Vol 10
(1)
◽
pp. 133-141
◽
1964 ◽
Vol 10
(1)
◽
pp. 109-127
◽
1972 ◽
Vol 1
(4)
◽
pp. 153-160
◽
Human medicines European public assessment report (EPAR): Erelzi, etanercept, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid,Spondylitis, Ankylosing, Date of authorisation: 23/06/2017, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Erelzi, etanercept, Arthritis, Psoriatic,Psoriasis,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid,Spondylitis, Ankylosing, Date of authorisation: 23/06/2017, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Orencia, abatacept, Arthritis, Psoriatic,Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid, Date of authorisation: 21/05/2007, Revision: 27, Status: Authorised